Concepedia

N. B. Haas

NB

4

Publications

276

Citations

4

H-Index

1997

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

N. B. Haas is an author at Dana-Farber Cancer Institute specializing in pharmacotherapy, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

1997–2011

4

Publications

4

Magnetic Resonance Imaging in the Diagnosis of Acute Injured Distal Tibiofibular Syndesmosis

Thomas J. Vogl, K. Hochmuth, Thomas Diebold et al. · Investigative Radiology · 1997 · 137 citations

Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial.

Maha Hussain, Matthew Ryan Smith, C. Sweeney et al. · Journal of Clinical Oncology · 2011 · 110 citations

, , +18

ECOG 8802: Phase II trial of doxorubicin (Dox) and gemcitabine (Gem) in metastatic renal cell carcinoma (RCC) with sarcomatoid features

N. B. Haas, Judith Manola, Michael Pins et al. · Journal of Clinical Oncology · 2009 · 18 citations

, , +19

Phase II study of sorafenib and docetaxel in men with metastatic castration resistant prostate cancer (mCRPC)

Jeremy Cetnar, Mark Rosen, David J. Vaughn et al. · Journal of Clinical Oncology · 2009 · 11 citations

, , +18

Rows per page

1–4 of 4